1. Pharmaceutical/Medical Marketing Jasmine Williams

2. Definition Any activity–advertising, 'detailing,' 'freebies,' and sponsoring of conferences and symposia–by a drug company which is intended to ↑ the sales of its products.

3. Education & Training Five-year Bachelors of Science in Pharmacy as a Professional Degree.

4. Main Duties & Responsibilities, Nature of Work, Working Conditions Depending on the size of the practice & staff, the Medical Receptionist's duties could vary slightly. Answering the phones is always the primary function. This includes Fielding calls & Transferring them to the appropriate person, or taking a message from the caller. Many medical receptionists also are responsible for scheduling patients' appointments, which is very important to the success of the practice. Medical receptionists are often busy setting, changing, or canceling appointments in addition to answering the phones.

5. Qualifications You have to take a State Regulated Exam.

6. Wage or Salary Range Most beginning Pharmaceutical Reps. will make a base Pharmaceutical Sales Salary of $40k-55k, depending on the type of experience you have & the number of years you’ve invested in your previous Career(s).

7. Employment Outlook Ten years from now the Pharmaceutical Industry is going to be a very different Industry than it is today; & looking back from that point we will see that the foundation for many of the changes to the Pharmaceutical Business model were laid in 2009. In Part One of a four part commentary on the Outlook for 2009, We focus on the choice between Portfolio Diversification Vs. New Product Development.

8. Opportunities for Advancement The big opportunity to out-perform in 2009 is to own the names that are going to be acquired. We have no crystal ball, but names that certainly look attractive & fit the model for a large pharmaceutical company to gobble them up include Biogen-Idec, Amylin Pharmaceuticals, Vertex Pharmaceuticals, Acorda Therapeutics, Osiris Therapeutics, Auxilium Pharmaceuticals, OSI Pharmaceuticals, & Elan Corp. All of these companies have what big Pharma is looking for-novel compounds with potential blockbuster sales levels at reasonable valuations.